sorafenib has been researched along with chir 98014 in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (chir 98014) | Trials (chir 98014) | Recent Studies (post-2010) (chir 98014) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 12 | 0 | 10 |
| Protein | Taxonomy | sorafenib (IC50) | chir 98014 (IC50) |
|---|---|---|---|
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 4 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 0.007 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.0031 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, ME; Braun, CA; Getlik, M; Grütter, C; Gutbrod, O; Mayer-Wrangowski, SC; Pérez-Martín, J; Rauh, D; Richters, A; Schreier, PH; Simard, JR | 1 |
1 other study(ies) available for sorafenib and chir 98014
| Article | Year |
|---|---|
Targeting GSK3 from Ustilago maydis: type-II kinase inhibitors as potential antifungals.
Topics: Amino Acid Sequence; Antifungal Agents; Crystallography, X-Ray; Drug Delivery Systems; Glycogen Synthase Kinase 3; Humans; Molecular Sequence Data; Protein Kinase Inhibitors; Ustilago | 2012 |